CONTROLLED TRIAL OF PRIMARY AND SECONDARY PREVENTION PROGRAM FOR LYME DISEASE

$157,130P60FY2000ARNIH

Brigham And Women'S Hospital, Boston MA

Investigators

Linked publications & trials

Paper 20812122 Paper 18668600 Paper 16750964 Paper 16304727 Paper 15662641 Paper 15593366 Paper 15529351 Paper 15478156 Paper 15283621 Paper 15258272 Paper 15188360 Paper 15022327 Paper 14872457 Paper 14635288 Paper 14635286 Paper 14613266 Paper 12895593 Paper 12729051 Paper 12728419 Paper 12687505 Paper 12671102 Paper 12586227 Paper 12571867 Paper 12533568 Paper 12533567 Paper 12483739 Paper 12465149 Paper 12450463 Paper 12432940 Paper 12392045 Paper 12090888 Paper 12064846 Paper 12064581 Paper 12021671 Paper 12000666 Paper 11851219 Paper 11757052 Paper 11750189 Paper 11741066 Paper 11701783 Paper 11585485 Paper 11572745 Paper 11550979 Paper 11444993 Paper 11414264 Paper 11409669 Paper 11382253 Paper 11352253 Paper 11275450 Paper 11268230 Paper 11252114 Paper 11246687 Paper 11242315 Paper 11124731 Paper 11093457 Paper 11073744 Paper 11059438 Paper 11014346 Paper 10982093 Paper 10852277 Paper 10852264 Paper 10788859 Paper 10752970 Paper 10743808 Paper 10673220

Abstract

The description of Lyme disease in 1976 and subsequent characterization of its mode of transmission, causative organism and treatment is one of the most important advances in rheumatology in the last 20 years. In theory Lyme disease could be prevented eradicated but in practice it continues to grow as public health problem. We propose a large simple randomized controlled trail of 40,000 subjects to evaluate an innovative educational primary prevention program directed towards a high-risk population, travelers to an island with the highest reported rates of Lyme disease in North America. Ferry boats to Nantucket Island will be randomized to Experimental intervention which is based on contemporary health education principles or to a Control intervention. An economic evaluation will be conducted in the context of the trial.

View original record on NIH RePORTER →